Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns

Metabolic syndrome, characterized by central obesity, hypertension, and hyperlipidemia, increases the morbidity and mortality of cardiovascular disease, type 2 diabetes, nonalcoholic fatty liver disease, and other metabolic diseases. It is well known that insulin resistance, especially hepatic insul...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Zuqing, Nie, Yutong, Huang, Xiufang, Zhu, Ying, Feng, Bing, Tang, Lipeng, Zheng, Guangjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795753/
https://www.ncbi.nlm.nih.gov/pubmed/31649547
http://dx.doi.org/10.3389/fphar.2019.01193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795753/
https://www.ncbi.nlm.nih.gov/pubmed/31649547
http://dx.doi.org/10.3389/fphar.2019.01193

Ejemplares similares